Select Your Language

CUPID LIMITED:Manufacturers and Suppliers of male and female condoms





Trading members of the Exchange are hereby informed that the under mentioned new securities of Cupid Limited (Scrip Code No. 530843 ISIN No: INE509F01011) are listed and permitted for trading on the Exchange with effect from Monday, June 13, 2011.

           
Security Details
6,42,100 Equity Shares of Rs.10/- each issued at premium of Rs.0.50 per share allotted against conversion of warrants to Promoters preferential basis.
   
These shares are ranking pari-passu with the existing equity shares of the company.
Date of Allotment
07/04/2011
Dist. Nos.
89,72,901 - 96,15,000
Issue Price
Rs.10.50


Lock in details
No. of Securities
Dist. Nos.
Date upto which under lock-in

6,42,100
89,72,901 - 96,15,000
07/04/2014


About Company: Cupid Ltd. Company is a leading manufacturer of quality male condoms. Headquartered in Mumbai, India it has one of the largest manufacturing facilities in India. Company has its marketing offices in New Delhi, India and Cleveland, USA. Cupid Ltd. also has USA FDA approval to export its product to its customers in United States.

Cupid Ltd. was founded in collaboration with world leader Green mate Corporation. Its ultra modern facility having current capacity of 360 million pieces per annum with pollution control measure and expanding is located about 200 Km. from Mumbai, India near the scenic resort town of Nasik. It had annual turnover of approx. Rs. 18 crore (USD 4.5 million) in the year ending Mar 31, 2007 and targetting for turnover of approx. Rs. 24 crore (USD 6 million) in the year ending Mar 31, 2008.

Cupid Ltd. is public limited company listed in Bombay Stock Exchange (BSE) since 1995. It commenced its commercial production in Jan 1997 under the strict supervision and training by Korean Technicians.

Cupid Ltd. has an active R&D center in addition to its main production facility. Cupid Ltd is actively involved in research related to HIV/AIDS prevention technology like female condoms .Cupid works with healthcare professionals, governments and organizations to support them in promoting good sexual health and the importance of consistent condom use to prevent HIV and other STDs. In order to execute its responsibility to help the society control AIDS and STD and control growth rate of population, Cupid has an important role to play “To Help the world play safe”.

Cupid Ltd. is manufacturing and successfully marketing condoms to India, Korea, Russia, South Africa, Australia, Turkey, Nigeria, Jamaica and many African & Latin American countries. Cupid offers various types of condoms such as Plain, Dotted, Colored, with or without Flavors and spermicidal under international known and accepted brand names such as Green-love, Bid-Dom, Hi-Life and Black Cobra. It also manufactures quality products under brands specified by customers.

Financial Result: Sales rise 59.86% to Rs. 7.05 crore

Cupid reported net profit of Rs. 0.43 crore in the quarter ended March 2011 as against net loss of Rs. 0.37 crore during the previous quarter ended March 2010. Sales rose 59.86% to Rs. 7.05 crore in the quarter ended March 2011 as against Rs. 4.41 crore during the previous quarter ended March 2010.

For the unaudited full year, net profit reported to Rs. 0.45 crore in the year ended March 2011 as against net loss of Rs. 1.94 crore during the previous year ended March 2010. Sales rose 124.47% to Rs. 19.08 crore in the year ended March 2011 as against Rs. 8.50 crore during the previous year ended March 2010.


Particulars
Quarter Ended
Year Ended

Mar. 2011
Mar. 2010
% Var.
Mar. 2011
Mar. 2010
% Var.
Sales
7.05
4.41
60
19.08
8.50
124
OPM %
13.33
7.26
84
13.68
-8.24
266
PBDT
0.82
0.10
720
1.86
-1.53
LP
PBT
0.43
-0.26
LP
0.45
-2.92
LP
NP
0.43
-0.37
LP
0.45
-1.94
LP

Cupid announced that it has been awarded order for supply 61.24 million pieces of condoms from the ministry of health and family welfare, Government of India aggregating amounting to Rs 96.33 million dated sep 2010.

NOTE: Investor can invest in this stock for long term (5-8 months) @ 7.00 Rs. Target 15.00 Rs .